The Enormous Promise of Psychedelics for Sustaining Health, Happiness and Sanity
(AlterNet) A researcher in a suit and tie strolls past with a graduate student in rainbow leggings and a red bandana. They’re discussing smoking addiction cessation research using the drug psilocybin—the active hallucinogen isolated from the fungus Psilocybe mexicana, or “magic mushrooms.” It is the conclusion of the Psychedelic Science Conference dinner on April 20 and the pair filters with a crowd of hundreds through the exit doors of the grand ballroom in Oakland’s Marriott Hotel.
Lagging behind are Rick Doblin, founder and executive director of theMultidisciplinary Association for Psychedelic Studies (MAPS), and a gaggle of dinner attendees who hover around Doblin in hopes that they might share a few words with the man of the hour. MAPS is the non-profit research and educational organization behind the conference, and works to develop psychedelics and marijuana into legal prescription drugs.
(via anti-propaganda)
(Source: mehreenkasana)







